Fast Money: Rapid Recap - The first and only official show synopsis
RSS FEED
FAST MONEY'S FAVORITE WEBSITES
RECENT POSTS
- Your Next Trades: RIM, Energy and Newmont
- Burned by the Homebuilders ETF
- Downside in Facebook May Continue to $25: Options Pro
- Top Analyst Reveals 5 Top Semi Stocks
- Your First Move For Tuesday May 29th
- Chesapeake Should Rally Into $20’s: Pro Trader
- Najarian: Yahoo! a Must Own Stock
- Marc Faber: 100% Chance of Global Recession
FAST MONEY FEATURES
FAST MONEY POLLGet in the post game. Respond to our "Question of the Day" right now.
TRADE SCHOOLGrab a pencil because school is in session and the Fast Money traders are teaching class.
FAST MONEY PODCASTSDownload Fast Money onto your MP3 Player.
FAST MONEY WIDGETGrab this all-in-one application and get recaps of the show sent right to your desktop or blog.
SHOP FOR FAST MONEY MERCHANDISEGet your game on with Fast Money gear.
FAST MONEY PHOTOS!Check out our scrapbook. These "pix" are guaranteed winners.
NEWSLETTERSign up and receive a daily email from the Fast Money team!
FAST MONEY MOBILE ALERTSGet advanced information about the next Fast Money.
Your First Move For Wednesday September 8th
Text Size 
Producer
 |
Here’s our Fast Money Final Trade. Our gang gives you tomorrow’s best trades, right now.
Tim Seymour suggests long Barclay’s [BCS
Loading...
()
] on the dip.
Guy Adami recommends long Human Genome [HGSI
Loading...
()
] (scroll down for all the details!)
Karen Finerman prefers long IBB [IBB
Loading...
()
] as a bet on further consolidation in biotech.
Anthony Scaramucci thinks Hewlett Packard [HPQ
Loading...
()
] is a buy. “I think there are better quarters to come,” he explains.
Steve Cortes suggests long UNP [UNP
Loading...
()
]. “I like the rails here,” he says.
--------------
AFTER HOURS ACTION: ZYMOGENETICS
After the bell, Bristol-Myers Squibb [BMY
Loading...
()
] said it would acquire biotechnology company ZymoGenetics [ZGEN
Loading...
()
]. for $885 million, or $9.75 per share a 77% premium over the closing price.
ZymoGenetics is based in Seattle and makes Recothrom, a drug used to reduce bleeding during surgeries. It is also developing a potential hepatitis C drug and experimental treatments for skin cancer and atopic dermatitis.
What’s the trade?
I’d play the space long Human Genome [HGSI
Loading...
()
], says Guy Adami. I wouldn’t be surprised to hear Glaxo make overtures for this company.
Click here to see other Final Trade posts.
______________________________________________________
Got something to say? Send us an e-mail at and your comment might be posted on the Rapid Recap! Prefer to keep it between us? You can still send questions and comments to .
Trader disclosure: On September 7th, 2010, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Seymour owns (AAPL), (BAC), (INTC), (MON), (POT); Adami owns (AGU), (BTU), (NUE), (C), (GS), (INTC), (MSFT); Adami’s wife works at Merck; Cortes owns (SFD), (BMO), (TD), (FCX), (BHP); Cortes owns the British Pound; Finerman and Finerman’s firm owns (BAC); Finerman owns (GOOG); Finerman’s firm owns (HPQ); Finerman’s firm owns (IBM); Finerman and Finerman’s firm owns (JPM); Finerman owns (ORCL); Finerman owns (POT) options; Finerman's firm is short (IJR); Finerman's firm is short (MDY); Finerman's firm is short (SPY); Finerman's firm is short (IWM); Finerman’s firm owns S&P 500 puts; Finerman’s firm owns Russell 2000 puts
For Anthony Scaramucci
Scaramucci & SkyBridge Capital own (AAPL)
Scaramucci & SkyBridge Capital own (AMZN)
Scaramucci & SkyBridge Capital own (C)
Scaramucci & SkyBridge Capital own S&P 500
Scaramucci & SkyBridge Capital own Gold
For Heather Bellini
ISI does and seeks to do business with (ORCL) and has received non-investment banking compensation in the past 12 months
For Dennis Gartman
Funds managed by Gartman own Gold
For Ed Mills
***No Disclosures***
For Scott Nations
***No Disclosures***
Data is a real-time snapshot *Data is delayed at least 15 minutes
